Akkermansia muciniphila and blood sugar

What 2 graded rows on akkermansia muciniphila agree on for blood sugar, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Akkermansia muciniphila page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Akkermansia muciniphila page, with its PubMed record.

Supplement

Akkermansia muciniphila Choose another

2 rows · 134 people

Split. 1 row found an improvement and 1 found no difference.

No difference

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside.

From the rows

When published

The best-graded row, grade D, is a randomized trial of 76 people (2020) and found an improvement.

The row that found no difference is newer (2025) than the row that found an improvement (2020).

1 improved · 1 no difference

Grade DPost-meal glucose in type 2 diabetes (multi-strain product with Akkermansia) · Improved
RCT · n 76 · 2020 · Adults with type 2 diabetes
Twice daily (counts not stated in the abstract) · 12 weeks
Glucose area under the curve fell by 36.1 mg/dL/180 min versus placebo (P = 0.05), and HbA1c by 0.6 points; no safety or tolerability issues.
Row on the Akkermansia muciniphila page · PubMed 32675291 (opens PubMed)
Grade DWeight and HbA1c in type 2 diabetes with overweight · No difference
RCT · n 58 · 2025 · Adults with type 2 diabetes and overweight or obesity
Not stated in the abstract · 12 weeks
Weight and HbA1c fell in both groups with no between-group difference; in people with low baseline Akkermansia, the strain colonized well and lowered weight, fat mass and HbA1c.
Row on the Akkermansia muciniphila page · PubMed 39879980 (opens PubMed)